REVIEW article

Front. Immunol.

Sec. NK and Innate Lymphoid Cell Biology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1612352

This article is part of the Research TopicPrecision Therapeutics in Rare Cancers: Targeting Tumor Microenvironment and Biomarker-Driven ApproachesView all 5 articles

Unraveling NK Cell Heterogeneity through Single-Cell Sequencing: Insights from Physiological and Tumor Contexts for Clinical Applications

Provisionally accepted
Mingxin  ShenMingxin Shen1Yutong  LiuYutong Liu2Liang  ShaoLiang Shao1Meng  QuMeng Qu1Song  ShixinSong Shixin1Hao  ZhangHao Zhang1*Wei  SunWei Sun1*
  • 1The First Affiliated Hospital of China Medical University, Shenyang, China
  • 2Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

The final, formatted version of the article will be published soon.

Natural killer cells (NK cells) are important immune cells within the tumor microenvironment (TME) and are considered the first line of defense in tumor immunity. Although many studies have focused on the role of NK cells in tumor therapy, the heterogeneity of NK cells complicates the investigation of the complex mechanisms within the tumor microenvironment. Single-cell sequencing technology, with its high-resolution capability, reveals the gene expression profiles of individual NK cells, highlighting their heterogeneity and providing more accurate information for NK cell therapy. This article begins by addressing the mechanisms underlying the formation of NK cell heterogeneity, emphasizing the significance of differentiation, development, and tissue residency in establishing this heterogeneity. It also summarizes the advances in the study of NK cell heterogeneity under physiological conditions and in tumor environments using single-cell sequencing technology. Finally, it analyzes the dynamic changes of NK cells within the tumor microenvironment under various therapeutic approaches to explore drug effects and resistance mechanisms, as well as to optimize therapeutic options. Investigating the mechanisms of tumor progression and drug intervention at the single-cell level will provide new perspectives for personalized treatment strategies centered around NK cells.

Keywords: Single-RNA sequencing, NK cell, heterogeneity, Tumor Microenvironment, Drug intervention

Received: 15 Apr 2025; Accepted: 02 Jul 2025.

Copyright: © 2025 Shen, Liu, Shao, Qu, Shixin, Zhang and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hao Zhang, The First Affiliated Hospital of China Medical University, Shenyang, China
Wei Sun, The First Affiliated Hospital of China Medical University, Shenyang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.